ANDROCUR

This brand name is authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Estonia, France, Germany, Hong Kong SAR China, Ireland, Israel, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug ANDROCUR contains one active pharmaceutical ingredient (API):

1	Cyproterone UNII 4KM2BN5JHF - CYPROTERONE ACETATE
	Cyproterone acetate acts as an antiandrogen by blocking androgen receptors. It also has progestogenic activity, which exerts a negative feedback effect on hypothalamic receptors, so leading to a reduction in gonadotrophin release, and hence to diminished production of testicular androgens. Sexual drive and potency are reduced and gonadal function is inhibited.
	Read more about Cyproterone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ANDROCUR Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
ANDROCUR Tablet / Solution for injection	MPI, CA: SPM	Health Products and Food Branch (CA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03HA01	Cyproterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03H Antiandrogens → G03HA Antiandrogens, plain
Discover more medicines within G03HA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1270W, 8019C
BR	Câmara de Regulação do Mercado de Medicamentos	538912050012813, 538912050012913
CA	Health Products and Food Branch	00704423, 00704431
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00928110, 01551015, 02454691, 02474825, 02579062, 03293416, 03415902, 03903317, 03967760, 04419345, 04456139, 04522155, 04690160, 04690177, 04954765, 04954771, 07432180, 07663583, 08853245, 09760020, 10546591, 12725381, 16749533
EE	Ravimiamet	1064124
ES	Centro de información online de medicamentos de la AEMPS	52691
FR	Base de données publique des médicaments	61255738
GB	Medicines & Healthcare Products Regulatory Agency	105156, 343427
HK	Department of Health Drug Office	46443
HR	Agencija za lijekove i medicinske proizvode	HR-H-843981106
IE	Health Products Regulatory Authority	14194
IL	מִשְׂרַד הַבְּרִיאוּת	4645, 8
LT	Valstybinė vaistų kontrolės tarnyba	1000129
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	341M79
NL	Z-Index G-Standaard, PRK	17302, 2712
PL	Rejestru Produktów Leczniczych	100004443
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64041001, W64041002
SG	Health Sciences Authority	04639P
TN	Direction de la Pharmacie et du Médicament	17463021
TR	İlaç ve Tıbbi Cihaz Kurumu	8699546011667, 8699546013838
ZA	Health Products Regulatory Authority	29/21.12/0515, R/21.12/159, R/21.12/160